<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640364</url>
  </required_header>
  <id_info>
    <org_study_id>HCR051631</org_study_id>
    <nct_id>NCT03640364</nct_id>
  </id_info>
  <brief_title>Bilateral Sacrospinous Colposuspension (BSC) in the Female Genital Prolapse With Urinary Urge Symptomatology</brief_title>
  <official_title>Multicenter Prospective Non-randomised Trial of Bilateral Sacrospinous Colposuspension (BSC) in the Treatment of Female Genital Prolapse Accompanied by Urinary Urge Symptomatology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helios Medical Center Schleswig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helios Medical Center Schleswig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective non-randomised trial investigating the effect of vaginal vault Suspension on urge
      symptomatology in female patients with pelvic organ prolapse
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multicenter multinational Trial is performed in 250 female patients with pelvic organ
      prolapse (POP) and symptoms of urinary urge incontinence.

      Dependent on the presence or abscence of the uterus patients are treated with bilateral
      sacrospinous uterine or vaginal vault suspension (BSC) by means of a tape specifically
      designed for this purpose.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of BSC placement on symptoms of urinary urge expressed by change in clinical examination</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>The change in symptoms after the surgical intervention is evaluated by clinical examination . The clinical examination is descriptive, not quantitative and no units are applicable or reportable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in score of standardized ICIQ documentation</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>The International Consultation on Incontinence Questionnaire is used to evaluate Change in Quality of life and urge symptomatology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anatomical correction of female pelvic organ prolapse</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>Clinical examination of pelvic floor anatomy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Urinary Urge Incontinence</condition>
  <eligibility>
    <study_pop>
      <textblock>
        female patients with pelvic organ prolapse suffering from symptoms of urinary urge
        incontinence
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  urge urinary incontinence or symptoms thereof

          -  18 years old or older

          -  Compliance regarding data collection, therapy and follow-up

          -  written informed consent

          -  simultaneous performance of surgical colporrhaphy permitted

        Exclusion Criteria:

          -  pelvic organ prolapse without symptoms of urinary urge

          -  age less than 18 years

          -  no informed consent

          -  lack of compliance

          -  adverse reaction to polypropylene

          -  life expectancy less than anticipated duration of protocol

          -  ASA 4
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk G Kieback, MD,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Medical Center Schleswig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dirk G Kieback, MD, Ph.D</last_name>
    <phone>+49 4621 812</phone>
    <phone_ext>1271</phone_ext>
    <email>dirk.kieback@helios-gesundheit.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marek Volkmer, MD</last_name>
    <phone>+49 4621 812</phone>
    <phone_ext>1271</phone_ext>
    <email>marek.volkmer@helios-gesundheit.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helios Medical Center</name>
      <address>
        <city>Schleswig</city>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Volkmer, MD</last_name>
      <phone>+49 4621 812</phone>
      <phone_ext>1271</phone_ext>
      <email>marek.volkmer@helios-gesundheit.de</email>
    </contact>
    <contact_backup>
      <last_name>Mona Litz</last_name>
      <phone>+49 4621 812</phone>
      <phone_ext>1271</phone_ext>
      <email>mona.litz@elios-gesundheit.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 6, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>August 17, 2018</last_update_submitted>
  <last_update_submitted_qc>August 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helios Medical Center Schleswig</investigator_affiliation>
    <investigator_full_name>Dirk G. Kieback, M.D., Ph.D</investigator_full_name>
    <investigator_title>Head, Dept. of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>incontinence</keyword>
  <keyword>minimally invasive</keyword>
  <keyword>vaginal surgery</keyword>
  <keyword>macroporous</keyword>
  <keyword>lightweight</keyword>
  <keyword>mesh</keyword>
  <keyword>polypropylene</keyword>
  <keyword>POP</keyword>
  <keyword>urge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Urge</mesh_term>
    <mesh_term>Uterine Prolapse</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

